Tag: bio law

Patent Trolling: Why Bio & Pharmaceuticals Are At Risk

Robin Feldman
Nicholson Price II

Patent trolls—also known variously as non-practicing entities, patent assertion entities, and patent monetizers—are a top priority on legislative and regulatory reform agendas. In modern debates, however, the biopharmaceutical industry goes conspicuously unmentioned. Although the biopharmaceuticalindustry is paradigmatically centered on patents, conventional wisdom holds that it is largely unthreatened by trolls. This Article shows that the conventional wisdom is wrong, both theoretically and descriptively.... Read more about Patent Trolling: Why Bio & Pharmaceuticals Are At Risk

  • November 10, 2014
  • 17 Stan. Tech. L. Rev. 773